FAVEZELIMAB

UNII: H1396W7D1H
Preferred Substance Name: FAVEZELIMAB

2231068-83-8
ANTI-LAG3 MONOCLONAL ANTIBODY MK-4280
FAVEZELIMAB [INN]
FAVEZELIMAB [USAN]
FAVEZELIMAB [WHO-DD]
IMMUNOGLOBULIN G4 (227-PROLINE), ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3) (HUMAN-MUS MUSCULUS MONOCLONAL C88 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C88 .KAPPA.-CHAIN, DIMER
MAVEZELIMAB
MK4280
MK-4280

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

FAVEZELIMAB

Synonyms and Mappings

Resources

Note